← Back to Model Beat
Industry·1d ago·all news from July 31, 2026

Illumina CEO on Genomic Sequencing Opportunities and AI

Illumina CEO Jacob Thaysen stated that the company is focusing on integrating artificial intelligence to enhance the efficiency and analytical capabilities of genomic sequencing. This strategy aims to accelerate the adoption of genomic medicine by simplifying complex data interpretation for clinical and research applications.

Covered by 1 source

Related stories

IndustryAmazon reportedly scales back its Nova AI models and bets on a new Frontier research teamJul 28 · 27 sourcesIndustryFree 2.8-Trillion-Parameter AI Model Release by Moonshot AI: How Does This Bold Move Make Financial & Strategic Sense?Jul 28 · 18 sourcesIndustryEU Pledges €10 Billion in Public Funding for New AI Data CentersJul 30 · 8 sourcesIndustryMeta’s Free Cash Flow Dwindles to Lowest in Nearly Four YearsJul 29 · 18 sources